C U Pietrzik

Summary

Affiliation: University of Mainz
Country: Germany

Publications

  1. ncbi LRP1 modulates APP trafficking along early compartments of the secretory pathway
    Elaine Waldron
    Institute of Physiological Chemistry and Pathobiochemistry, Molecular Neurodegeneration, Johannes Gutenberg University Mainz, 55099 Mainz, Germany
    Neurobiol Dis 31:188-97. 2008
  2. ncbi APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms
    Simone Isbert
    Department of Pathobiochemistry, Molecular Neurodegeneration, University Medical Center of the Johannes Gutenberg University Mainz, Germany
    Cell Mol Life Sci 69:1353-75. 2012
  3. ncbi FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein
    Claus U Pietrzik
    Department of Neurosciences, University of California, San Diego, La Jolla, California 92093, USA
    J Neurosci 24:4259-65. 2004
  4. ncbi The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases
    S Soriano
    Department of Neurosciences, University of California San Diego, La Jolla, California 92093 0691, USA
    J Biol Chem 276:29045-50. 2001
  5. ncbi The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing
    Claus U Pietrzik
    Department of Neurosciences, University of California, San Diego, La Jolla 92093, USA
    EMBO J 21:5691-700. 2002
  6. ncbi Mechanisms of C-reactive protein-induced blood-brain barrier disruption
    Christoph R W Kuhlmann
    Institute of Physiology and Pathophysiology, Johannes Gutenberg University of Mainz, Mainz, Germany
    Stroke 40:1458-66. 2009
  7. ncbi Sequences from the low density lipoprotein receptor-related protein (LRP) cytoplasmic domain enhance amyloid beta protein production via the beta-secretase pathway without altering amyloid precursor protein/LRP nuclear signaling
    Il Sang Yoon
    Department of Neurosciences, University of California, San Diego, La Jolla, 92093, USA
    J Biol Chem 280:20140-7. 2005
  8. ncbi Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease
    T Pflanzner
    Institute of Pathobiochemistry, Molecular Neurodegeneration, University Medical Center of the Johannes Gutenberg University Mainz, 55099 Mainz, Germany
    Curr Alzheimer Res 7:578-90. 2010
  9. ncbi A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity
    S Weggen
    Department of Neurosciences, University of California San Diego, La Jolla, California 92093, USA
    Nature 414:212-6. 2001
  10. ncbi Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain
    Sascha Weggen
    Department of Neurosciences, University of California San Diego, La Jolla, California 92093, USA
    J Biol Chem 278:30748-54. 2003

Collaborators

Detail Information

Publications19

  1. ncbi LRP1 modulates APP trafficking along early compartments of the secretory pathway
    Elaine Waldron
    Institute of Physiological Chemistry and Pathobiochemistry, Molecular Neurodegeneration, Johannes Gutenberg University Mainz, 55099 Mainz, Germany
    Neurobiol Dis 31:188-97. 2008
    ..In addition, we provide evidence that APP metabolism occurs in close conjunction with LRP1 trafficking, highlighting a new role of lipoprotein receptors in neurodegenerative diseases...
  2. ncbi APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms
    Simone Isbert
    Department of Pathobiochemistry, Molecular Neurodegeneration, University Medical Center of the Johannes Gutenberg University Mainz, Germany
    Cell Mol Life Sci 69:1353-75. 2012
    ..Thus, suggesting that steric properties of KPI-APP might be the cause for weaker cis-interaction in the ER, compared to APP695. Finally, we provide evidence that APP/APLP1 heterointeractions are likewise initiated in the ER...
  3. ncbi FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein
    Claus U Pietrzik
    Department of Neurosciences, University of California, San Diego, La Jolla, California 92093, USA
    J Neurosci 24:4259-65. 2004
    ..These results clearly demonstrate that FE65 acts as a functional linker between APP and LRP...
  4. ncbi The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases
    S Soriano
    Department of Neurosciences, University of California San Diego, La Jolla, California 92093 0691, USA
    J Biol Chem 276:29045-50. 2001
    ..Thus, caspase cleavage of APP is unlikely to play a direct role in amyloidogenesis...
  5. ncbi The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing
    Claus U Pietrzik
    Department of Neurosciences, University of California, San Diego, La Jolla 92093, USA
    EMBO J 21:5691-700. 2002
    ..Therefore, we propose a model by which LRP functionally modulates APP processing, including those steps critical for Abeta production, through interactions of the cytosolic domains...
  6. ncbi Mechanisms of C-reactive protein-induced blood-brain barrier disruption
    Christoph R W Kuhlmann
    Institute of Physiology and Pathophysiology, Johannes Gutenberg University of Mainz, Mainz, Germany
    Stroke 40:1458-66. 2009
    ..The aim of this study was to examine whether CRP directly affects blood-brain barrier stability and to analyze the underlying signaling pathways...
  7. ncbi Sequences from the low density lipoprotein receptor-related protein (LRP) cytoplasmic domain enhance amyloid beta protein production via the beta-secretase pathway without altering amyloid precursor protein/LRP nuclear signaling
    Il Sang Yoon
    Department of Neurosciences, University of California, San Diego, La Jolla, 92093, USA
    J Biol Chem 280:20140-7. 2005
    ..These observations indicate that there are cellular pathways that may suppress Abeta generation but that can be altered to facilitate Abeta production...
  8. ncbi Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease
    T Pflanzner
    Institute of Pathobiochemistry, Molecular Neurodegeneration, University Medical Center of the Johannes Gutenberg University Mainz, 55099 Mainz, Germany
    Curr Alzheimer Res 7:578-90. 2010
    ....
  9. ncbi A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity
    S Weggen
    Department of Neurosciences, University of California San Diego, La Jolla, California 92093, USA
    Nature 414:212-6. 2001
    ....
  10. ncbi Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain
    Sascha Weggen
    Department of Neurosciences, University of California San Diego, La Jolla, California 92093, USA
    J Biol Chem 278:30748-54. 2003
    ....
  11. ncbi Amyloid precursor-like protein 1 influences endocytosis and proteolytic processing of the amyloid precursor protein
    Stephanie Neumann
    Adolf Butenandt Institut, Ludwig Maximilians University, Schillerstrasse 44, 80336 Munich, Germany
    J Biol Chem 281:7583-94. 2006
    ..In summary, our study provides a novel mechanism for APP shedding, in which APLP1 affects the endocytosis of APP and makes more APP available for alpha-secretase cleavage...
  12. ncbi Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription
    Elaine Waldron
    Institute of Physiological Chemistry and Pathobiochemistry, Molecular Neurodegeneration, Johannes Gutenberg University Mainz, 55099 Mainz, Germany
    Exp Cell Res 314:2419-33. 2008
    ..Therefore we provide strong evidence that an increase in AICD generation does not directly promote gene activation of previously proposed target genes...
  13. ncbi Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes
    Sabrina Utter
    Department of Neuropathology, University of Bonn, Bonn, Germany
    J Neuropathol Exp Neurol 67:842-56. 2008
    ..It is therefore tempting to speculate that apoE represents a pathogenetic link between SVD and AD...
  14. ncbi The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors
    Anne M Martin
    Institute of Physiological Chemistry and Pathobiochemistry, Molecular Neurodegeneration and Institute of Physiology, Johannes Gutenberg University Mainz, D 55099 Mainz, Germany
    J Biol Chem 283:12004-13. 2008
    ..These results provide new insights into the mechanism of a tPA-induced, LRP1-mediated gating mechanism for NMDA receptors...
  15. ncbi Functional role of lipoprotein receptors in Alzheimer's disease
    Sebastian Jaeger
    Institute of Physiological Chemistry and Pathobiochemistry, Molecular Neurodegeneration, Johannes Gutenberg University Mainz, Mainz, Germany
    Curr Alzheimer Res 5:15-25. 2008
    ..Although the involvement of LDLR family members in AD is not yet fully understood it becomes clear that they can directly affect APP production, Abeta-clearance and Abeta-transport over the blood brain barrier...
  16. ncbi The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice
    Sabine Ring
    Department of Bioinformatics and Functional Genomics, Institute for Pharmacy and Molecular Biotechnology, University of Heidelberg, D 69120 Heidelberg, Germany
    J Neurosci 27:7817-26. 2007
    ..Together, our data suggest that the APP C terminus is dispensable and that APPs alpha is sufficient to mediate the physiological functions of APP assessed by these tests...
  17. ncbi Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42
    Stefanie Leuchtenberger
    Emmy Noether Research Group, Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg University Mainz, Mainz, Germany
    J Neurochem 96:355-65. 2006
    ..Taken together, these results seem to exclude a mechanistic involvement of ROCK in the Abeta42-lowering activity of NSAIDs...
  18. ncbi Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for gamma-secretase
    Alberto Lleo
    Alzheimer Research Unit, Massachusetts Institute for Neurodegenerative Disorders, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
    J Biol Chem 280:27303-9. 2005
    ..In conclusion, LRP is a PS1 interactor and can compete with APP for gamma-secretase enzymatic activity...
  19. ncbi Functional role of the low-density lipoprotein receptor-related protein in Alzheimer's disease
    Elaine Waldron
    Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg University Mainz, Mainz, Germany
    Neurodegener Dis 3:233-8. 2006
    ..A more in-depth knowledge of the mechanisms regulating APP cleavage may offer additional targets for therapeutic intervention...